Rankings
▼
Calendar
SBFM Q1 2025 Earnings — Sunshine Biopharma, Inc. Revenue & Financial Results | Market Cap Arena
SBFM
Sunshine Biopharma, Inc.
$6M
Q1 2025 Earnings
Healthcare
Drug Manufacturers - Specialty & Generic
Income Statement
Revenue
$9M
+18.0% YoY
Gross Profit
$3M
30.7% margin
Operating Income
-$1M
-14.6% margin
Net Income
-$1M
-13.3% margin
EPS (Diluted)
$-0.44
QoQ Revenue Growth
-7.2%
Cash Flow
Operating Cash Flow
-$2M
Free Cash Flow
-$2M
Stock-Based Comp.
$0
Balance Sheet
Total Assets
$29M
Total Liabilities
$6M
Stockholders' Equity
$23M
Cash & Equivalents
$8M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$9M
$8M
+18.0%
Gross Profit
$3M
$2M
+18.1%
Operating Income
-$1M
-$1M
+4.1%
Net Income
-$1M
-$1M
+8.1%
← Q4 2024
All Quarters
Q2 2025 →